Perioperative use of methotrexate

Clinical and Experimental Rheumatology

Volumn 28, Issue 5 SUPPL. 61, 2010, Pages

  Heldmann, F ^a   Braun, J ^a  

^a RHEUMAZENTRUM RUHRGEBIET   (Germany)

Author keywords

Methotrexate; Postoperative complications; Rheumatoid arthritis

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; AZATHIOPRINE; MERCAPTOPURINE;

ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTIVE SURGERY; EVIDENCE BASED MEDICINE; HIP ARTHROPLASTY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JOINT PROSTHESIS; KNEE ARTHROPLASTY; LOW DRUG DOSE; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS LOOSENING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; RISK FACTOR; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION; BLOOD CELL COUNT; CORTICOSTEROID THERAPY; DIABETES MELLITUS; PERIPROSTHETIC JOINT INFECTION; REPLACEMENT ARTHROPLASTY; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HUMANS; METHOTREXATE; ORTHOPEDIC PROCEDURES; PERIOPERATIVE CARE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 78650580841     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. WILLKENS RF, WATSON MA, PAXSON CS: Low dose pulse methotrexate therapy in rheumatoid arthritis. J Rheumatol 1980;7:501-5.
2. WILLIAMS HJ, WILLKENS RF, SAMUELSON CO Jr et al.: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1985;28:721-30.
3. STEUER A, KEAT AC: Perioperative use of methotrexate-a survey of clinical practive in the UK. Br J Rheumatol 1997;36:1009-11.
4. GRENNAN DM, GRAY J, LOUDON J, FEAR S: Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001;60:214-7.
5. SANY J, ANAYA JM, CANOVAS F et al.: Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 1993;20:1129-32.
6. MURATA K, YASUDA T, ITO H, YOSHIDA M, SHIMIZU M, NAKAMURA T: Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Mod Rheumatol 2006;16:14-9.
7. CARPENTER MT, WEST SG, VOGELSANG SA, CASEY JONES DE: Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 1996;19:207-10.
8. PERHALA RS, WILKE WS, CLOUGH JD, SEGAL AM: Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 1991;34:145-52.
9. JAIN A, WITTBREUK M, BALL C, NANCHAHAL J: Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J Hand Surg Am 2002;27:449-55.
10. BRIDGES SL JR, LOPEZ-MENDEZ A, HAN KH, TRACY IC, ALARCON GS: Should methotrexate be discontinued before elective orthopaedic surgery in patients with rheumatoid arthritis? J Rheumatol 1991;18:984-8.
11. BIBBO C, ANDERSON RB, DAVIS WH, NORTON J: The influence of rheumatoid chemotherapy, age, and presence of rheumatoid nodules on postoperative complications in rheumatoid foot and ankle surgery: analysis of 725 procedures in 104 patients. Foot Ankle Int 2003;24:40-4.
12. VERSTAPPEN S M M, HOES JN, JACOBS J W G, ter BORG EJ, BJILSMA J W J: Occurrence and predictors of joint surgery in the Utrecht rheumatoid arthritis cohort. Ann Rheum Dis 2005;64:216.
13. Da SILVA E, DORAN MF, CROWSON CS, O'FALLON WM, MATTESON EL: Declining use of orthopaedic surgery in patients with rheumatoid arthritis? Results of a longterm, population based assessment. Arthritis Rheum 2003;49:216-20.
14. WOLFE F, ZWILLICH SH: The long-term outcomes of rheumatoid arthritis: A 23-year prospective longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1072-82.
15. BONGARTZ T, HALLIGAN CS, OSMON DR et al.: Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 2008;59:1713-20.
16. COLOMBEL JF, LOFTUS EV JR, TREMAINE WJ et al.: Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004;99:878-83.
17. BLAND KI, PALIN WE, VON FRAUNHOFER JA, Morris RR, ADCOCK RA, TOBIN GR 2ND: Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 1984;199:782-90.
18. GARNER RW, MOWAT AG, HAZLEMAN BL: Post-operative wound healing in patients with rheumatoid arthritis. Ann Rheum Dis 1973;32:273-4.
19. BUSTI AJ, HOOPER JS, AMAYA CJ, KAZI S: Effects of perioperative anti-inflammatory and immunomodulafing therapy on surgical wound healing. Pharmacotherapy 2005;25:1566-91.
20. KATZ JN, LARSON MG, GINSBURG KS: Reconsideration of the risk of post-arthroplasty infection in patients treated with methotrexate. Arthritis Rheum 1991;34:1624.
21. ALARCON GS, MORELAND LW, JAFFE K, PHILLIPS RM, BOCANEGRA T, RUSSELL IJ: The use of methotrexate perioperatively in patients with rheumatoid arthritis undergoing major joint replacement surgery: Will we ever have consensus about its use? J Clin Rheumtol 1996;2:6-8.
22. VISSER K, KATCHAMART W, LOZA E et al.: Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009;68:1086-93.
23. LOZA E, MARTINEZ-LOPEZ JA, CARMONA L: A systematic review on the optimum management of the use of methotrexate in rheumatoid arthritis patients in the perioperative period to minimise perioperative morbidity and maintain disease control. Clin Exp Rheumatol 2009;27:856-62.
24. SCHNEEWEISS S, SETOGUCHIS, WEINBLATT ME et al.: Anti-tumour necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum 2007;56:1754-64.
25. SOUVEREIN PC, BERARD A, VAN STAA TP et al.: Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case control study. Heart 2004;90:859-65.
26. GALVIN EM, O'DONNELL D, LEONARD IE: Rheumatoid Arthritis: A significant but often underestimated risk factor for perioperative cardiac morbidity. Anesthesiology 2005;103:910-11.